Open-angle glaucoma is often called the “silent thief of sight” because it causes slow, painless vision loss that many people don’t notice until significant damage has already occurred. Understanding how this disease is diagnosed—and catching it early—can make the difference between preserving your sight and facing irreversible vision loss.

Introduction: Who Should Undergo Diagnostics and When

Diagnosing open-angle glaucoma early is crucial because the damage it causes to your vision cannot be reversed. Once your optic nerve—the nerve that carries visual information from your eye to your brain—is damaged, the lost vision is gone permanently. This makes early detection through regular eye examinations absolutely essential, especially since most people experience no symptoms in the early stages of the disease.^[1]

You should seek diagnostic testing if you fall into certain higher-risk groups. Anyone over the age of 65 faces increased risk and should have comprehensive eye examinations regularly. If you are African-American, your risk begins much earlier—after age 40—and the disease tends to be more severe, developing at younger ages and leading to blindness six to eight times more often than in other populations. Black race increases the prevalence of glaucoma by a factor of four.^[6][11]

Family history matters significantly. If someone in your family has had glaucoma, your own chances of developing it increase considerably. Other conditions also raise your risk: if you have diabetes, high blood pressure, severe nearsightedness (called myopia), or if you have a thinner than average cornea—the clear front surface of your eye. Anyone using steroid medications, particularly eye drops or injections near the eye, should also be monitored closely, as these can contribute to elevated eye pressure.^[5][6]

Even if you don’t have obvious risk factors, it’s still wise to have regular comprehensive eye exams as you age. Open-angle glaucoma usually develops so gradually that you won’t notice anything wrong until the disease is quite advanced. By the time you realize you’re missing stairs when walking down, having trouble reading entire words, or struggling to see road signs while driving, substantial and permanent damage has likely already occurred to your optic nerve.^[1][7]

Diagnostic Methods for Identifying Open-Angle Glaucoma

Diagnosing open-angle glaucoma requires a comprehensive approach because no single test can definitively confirm the disease. Your eye care provider will typically perform several different examinations during your visit, each looking at a different aspect of your eye health. Together, these tests create a complete picture that helps distinguish glaucoma from other eye conditions and determine how far the disease has progressed.^[2]

Measuring Intraocular Pressure (Tonometry)

One of the most common tests is measuring the pressure inside your eye, called intraocular pressure or IOP. This test, known as tonometry, is important because elevated eye pressure is a major risk factor for developing glaucoma. During this test, your eye care provider will typically use a device that gently presses against your eye’s surface after numbing drops have been applied, or they might use a puff of air directed at your eye.^[3][10]

However, it’s crucial to understand that eye pressure alone doesn’t diagnose glaucoma. This is one of the most misunderstood aspects of the disease. While many people with glaucoma do have pressure higher than the typical range of 21 mm Hg or less, about one-third of patients with glaucoma have perfectly normal pressure but still develop optic nerve damage. These patients have what’s called normal-pressure glaucoma or low-tension glaucoma. On the flip side, more than two-thirds of people with elevated eye pressure never develop glaucoma at all—they’re considered “glaucoma suspects” and need monitoring but may never develop the disease.^[6][11]

Examining the Optic Nerve

The most critical part of diagnosing open-angle glaucoma is examining your optic nerve, which is located at the back of your eye. Your eye doctor will dilate your pupils with special drops, then use a bright light and magnifying lens to carefully study the appearance of your optic disc—the point where the optic nerve exits your eye. This part of the exam, called ophthalmoscopy, allows the doctor to look for characteristic changes that happen when glaucoma damages the nerve.^[2][10]

A healthy optic disc looks like a slightly vertically elongated circle with a small central depression called the cup. The tissue surrounding this cup, called the neurosensory rim, is made up of nerve fibers carrying visual information to your brain. In glaucoma, these nerve fibers gradually die off, causing the cup to enlarge and the rim to thin. Your doctor will look for several telltale signs: an increasing ratio between the size of the cup and the overall disc, thinning or notching of the rim, small hemorrhages crossing the disc margin, vertical elongation of the cup, and sharp changes in blood vessel angles.^[14]

Many eye care providers now use advanced imaging technologies to get even more detailed information about your optic nerve. Optical Coherence Tomography (OCT) creates high-resolution, three-dimensional images of your optic nerve and can measure the thickness of your retinal nerve fiber layer—the layer of nerve fibers that glaucoma destroys. This technology can detect changes so subtle that they might not be visible during a regular examination, helping catch the disease earlier.^[2]

Visual Field Testing (Perimetry)

Because glaucoma damages your peripheral vision first, testing your full field of vision is essential for both diagnosis and tracking disease progression. This test, called perimetry or visual field testing, is considered a cornerstone of glaucoma diagnosis and management.^[6][11]

During this test, you’ll look straight ahead into a bowl-shaped instrument while small lights flash in different locations throughout your peripheral vision. Each time you see a light, you press a button. The computer creates a detailed map showing any areas where you didn’t see the lights—these are your blind spots. In glaucoma, specific patterns of vision loss typically appear: you might develop a blind spot on the side near your nose (called a nasal step defect), an arc-shaped blind spot above or below your central vision (arcuate scotoma), a small round blind spot just off-center (paracentral scotoma), or a wedge-shaped dark area on the temple side (temporal wedge defect).^[1][8]

These tests need to be repeated regularly over time because comparing results from different visits helps your doctor determine whether the disease is progressing and whether your treatment is working. The pattern and location of visual field defects help distinguish glaucoma from other conditions that might cause similar symptoms.^[6]

Examining the Drainage Angle (Gonioscopy)

An important test for diagnosing open-angle glaucoma specifically is called gonioscopy. This examination looks at the drainage angle in your eye—the area where fluid should drain out. This is what distinguishes open-angle glaucoma from angle-closure glaucoma. In open-angle glaucoma, this angle looks open and unobstructed, even though fluid isn’t draining properly. The problem lies deeper within the drainage system, in a spongy tissue called the trabecular meshwork.^[2][4]

During gonioscopy, your doctor places a special contact lens on your eye (after numbing it with drops) and uses a microscope to view the drainage angle. This test helps rule out angle-closure glaucoma, where the drainage opening itself is blocked or too narrow, which is a different condition requiring different treatment.^[12]

Measuring Corneal Thickness (Pachymetry)

The thickness of your cornea can affect eye pressure readings and your risk of developing glaucoma. A test called pachymetry uses ultrasound waves to measure how thick your cornea is. People with thinner corneas face higher risk for open-angle glaucoma, and having a thin cornea can also mean that pressure readings are artificially lower than they truly are. Your doctor takes this measurement into account when interpreting your other test results and assessing your overall risk.^[3][5]

Distinguishing Glaucoma from Other Conditions

Several other eye conditions can cause symptoms similar to glaucoma, which is why comprehensive testing is so important. Conditions affecting the optic nerve from other causes—such as poor blood flow, tumors, or inflammation—might initially look like glaucoma. Certain inherited conditions can also mimic glaucoma’s appearance. Your doctor will consider your complete medical history, family history, and the full range of test results to make an accurate diagnosis and rule out these other possibilities.^[2]

The combination of all these tests—pressure measurement, optic nerve examination, visual field testing, drainage angle assessment, and corneal thickness measurement—gives your doctor the information needed to diagnose open-angle glaucoma confidently, assess its severity, and create an appropriate treatment plan. Because glaucoma is a chronic, progressive disease, these same tests will be repeated regularly over time to monitor whether the disease is stable or worsening.^[12]

Diagnostics for Clinical Trial Qualification

When patients with open-angle glaucoma are being considered for enrollment in clinical trials testing new treatments, they typically undergo the same comprehensive diagnostic evaluations used in standard clinical care, but often with more frequent monitoring and more stringent criteria. Clinical trials need very precise measurements to determine whether a new treatment is working, so the testing protocols tend to be more rigorous.^[2]

The cornerstone diagnostic test for qualifying patients for glaucoma clinical trials is usually comprehensive visual field testing using standardized perimetry. Researchers need baseline measurements of exactly how much vision loss each patient has before starting any new treatment. They can then repeat these tests at regular intervals to see whether the new treatment slows, stops, or reverses the progression of visual field defects compared to patients receiving standard treatments or placebo.^[12]

Intraocular pressure measurements are also standard qualifying criteria for most clinical trials. Trials often specify an exact range of eye pressures that participants must have—for example, some studies might only include patients whose pressure is above a certain threshold despite already being on other treatments, while others might focus specifically on patients with normal-pressure glaucoma. Pressure is typically measured multiple times on different days to ensure accurate baseline readings and to understand how much a patient’s pressure naturally fluctuates throughout the day.^[2]

Optic nerve imaging using optical coherence tomography has become increasingly important in clinical trial qualification. This technology allows researchers to detect extremely subtle changes in the nerve fiber layer thickness that might indicate whether a disease is progressing or stabilizing. OCT measurements provide objective, quantifiable data that can be compared across different time points and between different patients, making them valuable for research purposes.^[12]

Most clinical trials also require gonioscopy to confirm that participants truly have open-angle glaucoma rather than angle-closure glaucoma or another form of the disease. The drainage angle must be documented as open before a patient can be enrolled in a trial specifically studying open-angle glaucoma treatments. This ensures that all participants in the study have the same type of glaucoma, making the results more reliable and meaningful.^[2]

Researchers may also measure corneal thickness as part of the qualification process, since this affects the accuracy of pressure readings. Additionally, some trials exclude patients with extremely thick or thin corneas to ensure more uniform study populations. A detailed medical history is always collected, and trials typically have specific inclusion and exclusion criteria based on age, ethnicity, other medical conditions, medications being taken, and how advanced the glaucoma has become. Some trials only accept patients with early-stage disease, while others specifically study treatments for advanced glaucoma.^[6]

Throughout a clinical trial, participants usually undergo these same diagnostic tests much more frequently than they would in regular clinical care—often every few months or even monthly. This intensive monitoring helps researchers detect even small changes that might indicate whether the new treatment is effective. While this requires more time commitment from participants, it also means they receive extremely thorough monitoring of their eye health throughout the study period.^[2]